Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PSNL · against 395 other Healthcare companies of similar size
Ranked #298 of 396 · scores higher than 24% of peers
Bars: peers in each 10-point band of the growth score53 peers with a growth score of 20–29, including PSNL · Click a bar to see the companies
Mainly because of its revenue growth and 3-year revenue growth, which are weaker than most Healthcare peers.
| Metric | PSNL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 398 reported | -13.3% | 6.3% | 13% | 33% | |
| Earnings per share growthHigher is better · 223 reported | Not reported | 10.1% | — | — | 33% |
| 3-year revenue growthHigher is better · 388 reported | 1.2% | 7.2% | 30% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 1 | 1.4B USD | 99 | 73 | |
| 1 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 1 | 2.1B USD | 99 | 96 | |
| 1 | 2.8B USD | 99 | 51 | |
| 293 | 3.0B EUR (≈$3.3B) | 27 | 62 | |
| 298 | 7.9B CNY (≈$1.1B) | 26 | 64 | |
| 298 | 14.2B HKD (≈$1.8B) | 26 | 64 | |
| 298 | 8.0B CNY (≈$1.1B) | 26 | 48 | |
| 298 | 1.7B USD | 26 | 21 | |
| 302 | 8.6B CNY (≈$1.2B) | 25 | 50 | |
| 302 | 8.9B CNY (≈$1.2B) | 25 | 62 | |
| 302 | 12.1B CNY (≈$1.7B) | 25 | 15 | |
| 302 | 174.8B JPY (≈$1.2B) | 25 | 45 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score